NuSirt Sciences, Inc. is a biotechnology company dedicated to developing innovative treatments for metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company has created a unique technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its lead product, NS-0100, merges the natural compound leucine with a low dose of metformin, which is commonly used for managing early type 2 diabetes but often causes gastrointestinal side effects that limit patient tolerance. Currently, NuSirt is conducting Phase 2 clinical trials to determine the most effective dosage of NS-0100. The company has filed eleven patent applications, with two already issued, and has successfully completed several clinical and pre-clinical studies based on its proprietary technologies. Founded in 2007 and based in Nashville, Tennessee, NuSirt Sciences continues to focus on advancing solutions for chronic diseases, particularly those related to metabolic dysfunction.
NuSirt Sciences, Inc. is a biotechnology company dedicated to developing innovative treatments for metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company has created a unique technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its lead product, NS-0100, merges the natural compound leucine with a low dose of metformin, which is commonly used for managing early type 2 diabetes but often causes gastrointestinal side effects that limit patient tolerance. Currently, NuSirt is conducting Phase 2 clinical trials to determine the most effective dosage of NS-0100. The company has filed eleven patent applications, with two already issued, and has successfully completed several clinical and pre-clinical studies based on its proprietary technologies. Founded in 2007 and based in Nashville, Tennessee, NuSirt Sciences continues to focus on advancing solutions for chronic diseases, particularly those related to metabolic dysfunction.
StreamWeaver
Series A in 2013
StreamWeaver is a software company based in Nashville, Tennessee, that specializes in developing innovative technology solutions. Its flagship product is a multi-angle mobile video application that allows users to connect and record videos together, automatically generating split-screen content. In addition to its video offerings, StreamWeaver provides a technology platform that facilitates the integration and streaming of data across various IT tools. This platform enables near real-time data connectivity with event-driven automation and comprehensive observability, aimed at reducing integration costs and enhancing productivity for clients.
American Hometown Media
Seed Round in 2013
American Hometown Media, Inc. is a digital media company based in Franklin, Tennessee, that specializes in connecting with American home cooks through its internet platform. Founded in 2011, the company continues the tradition of analog publishing by syndicating editorial content that celebrates hometown cooks to community newspapers, magazines, and various media outlets across the nation. Its offerings include Just A Pinch Recipes, a digital social network focused on recipes and coupons for home cooks, and Just A Pinch Syndicated Media, which delivers content related to home cooking and American culture to a wide audience. American Hometown Media leverages its roots in traditional media while embracing digital innovation, reaching approximately two million households weekly with its syndicated columns.
StreamWeaver
Series A in 2013
StreamWeaver is a software company based in Nashville, Tennessee, that specializes in developing innovative technology solutions. Its flagship product is a multi-angle mobile video application that allows users to connect and record videos together, automatically generating split-screen content. In addition to its video offerings, StreamWeaver provides a technology platform that facilitates the integration and streaming of data across various IT tools. This platform enables near real-time data connectivity with event-driven automation and comprehensive observability, aimed at reducing integration costs and enhancing productivity for clients.
StreamWeaver
Seed Round in 2012
StreamWeaver is a software company based in Nashville, Tennessee, that specializes in developing innovative technology solutions. Its flagship product is a multi-angle mobile video application that allows users to connect and record videos together, automatically generating split-screen content. In addition to its video offerings, StreamWeaver provides a technology platform that facilitates the integration and streaming of data across various IT tools. This platform enables near real-time data connectivity with event-driven automation and comprehensive observability, aimed at reducing integration costs and enhancing productivity for clients.
NuSirt Sciences, Inc. is a biotechnology company dedicated to developing innovative treatments for metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company has created a unique technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its lead product, NS-0100, merges the natural compound leucine with a low dose of metformin, which is commonly used for managing early type 2 diabetes but often causes gastrointestinal side effects that limit patient tolerance. Currently, NuSirt is conducting Phase 2 clinical trials to determine the most effective dosage of NS-0100. The company has filed eleven patent applications, with two already issued, and has successfully completed several clinical and pre-clinical studies based on its proprietary technologies. Founded in 2007 and based in Nashville, Tennessee, NuSirt Sciences continues to focus on advancing solutions for chronic diseases, particularly those related to metabolic dysfunction.
NuSirt Sciences, Inc. is a biotechnology company dedicated to developing innovative treatments for metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company has created a unique technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its lead product, NS-0100, merges the natural compound leucine with a low dose of metformin, which is commonly used for managing early type 2 diabetes but often causes gastrointestinal side effects that limit patient tolerance. Currently, NuSirt is conducting Phase 2 clinical trials to determine the most effective dosage of NS-0100. The company has filed eleven patent applications, with two already issued, and has successfully completed several clinical and pre-clinical studies based on its proprietary technologies. Founded in 2007 and based in Nashville, Tennessee, NuSirt Sciences continues to focus on advancing solutions for chronic diseases, particularly those related to metabolic dysfunction.
American Hometown Media
Seed Round in 2012
American Hometown Media, Inc. is a digital media company based in Franklin, Tennessee, that specializes in connecting with American home cooks through its internet platform. Founded in 2011, the company continues the tradition of analog publishing by syndicating editorial content that celebrates hometown cooks to community newspapers, magazines, and various media outlets across the nation. Its offerings include Just A Pinch Recipes, a digital social network focused on recipes and coupons for home cooks, and Just A Pinch Syndicated Media, which delivers content related to home cooking and American culture to a wide audience. American Hometown Media leverages its roots in traditional media while embracing digital innovation, reaching approximately two million households weekly with its syndicated columns.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.